Emil Kuriakose
Chief Medical Officer · Terns Pharmaceuticals, Inc.
- 2024
- May 5, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Emil Kuriakose files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amy L. Burroughs - $3.80M in TERN purchases and sales in the last 12 months
- Jill M. Quigley - $441K in TERN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Emil Kuriakose?
Emil Kuriakose is a corporate insider, tracked as Chief Medical Officer of Terns Pharmaceuticals, Inc. (TERN). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Emil Kuriakose last file a Form 4?
The most recent primary Form 4 on record is dated 5 May 2026, one of 6 filings going back to 2024.
Has Emil Kuriakose been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($61K) across all tracked filings.
